Clinical Trial Update: Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating DYN101 for centronuclear myopathy has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Centronuclear Myopathy

Drugs mentioned

• DYN101 (DYN101)

Snippet

Sponsor: Dynacure | Conditions: Centronuclear Myopathy | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-06-27